The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice.
双重 PPARα/γ 激动剂 tesaglitazar 可阻止 APOE*3Leiden.CETP 转基因小鼠中已存在的动脉粥样硬化的进展
期刊:British Journal of Pharmacology
影响因子:7.7
doi:10.1111/j.1476-5381.2008.00109.x
van der Hoorn J W A, Jukema J W, Havekes L M, Lundholm E, Camejo G, Rensen P C N, Princen H M G
